Overview of Dr. Desai
Dr. Pinkal Desai is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from B. J. Medical College Ahmedabad and has been in practice 13 years. She is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.
Office
520 E 70th St
Starr 341
New York, NY 10021
Education & Training
Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2010 - 2013
Wayne State University School of MedicineResidency, Internal Medicine, 2007 - 2010
B. J. Medical College AhmedabadClass of 2004
Certifications & Licensure
NY State Medical License 2013 - 2024
MI State Medical License 2007 - 2013
Clinical Trials
- A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms Start of enrollment: 2016 Mar 15
Publications & Presentations
PubMed
- 45 citationsHealthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative.Bernhard Haring, Alexander P. Reiner, Jingmin Liu, Deirdre K Tobias, Eric A. Whitsel
Journal of the American Heart Association. 2021-03-02 - 285 citationsInherited causes of clonal haematopoiesis in 97,691 whole genomes.Alexander G. Bick, Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao
Nature. 2020-10-14 - 37 citationsMendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.Tetsushi Nakao, Alexander G Bick, Margaret A Taub, Seyedeh M Zekavat, Md M Uddin
Science Advances. 2022-04-08
Journal Articles
- Somatic Mutations Precede Acute Myeloid Leukemia Years Before DiagnosisSangmin Lee, Pinkal Desai, Gail J Roboz, Ellen K Ritchie, Nature
Abstracts/Posters
- Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive ChemotherapyPinkal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- CPX-351 As First Intensive Therapy for Elderly Patients with AMLPinkal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- PTPN11 Mutated Acute Myeloid Leukemia (AML) Features an Abundant Epichaperome Network and Is Sensitive to the Epichaperome Inhibitor PU-H71Pinkal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?September 6th, 2024- Intermediate-Risk Acute Myeloid LeukemiaMay 19th, 2022
- COVID-19 More Severe in Patients with Active Acute Leukemia, Myelodysplastic SyndromeDecember 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
